Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$358K Buy
1,837
+271
+17% +$52.9K 0.25% 131
2018
Q3
$325K Hold
1,566
0.17% 134
2018
Q2
$289K Buy
1,566
+868
+124% +$154K 0.15% 136
2018
Q1
$119K Sell
698
-6,145
-90% -$1.13M 0.12% 121
2017
Q4
$1.19M Buy
+6,843
New +$1.21M 0.71% 56

Other funds holding AMGN

Kaizen Advisory's AMGN Position: Q4 2018 in Review

Kaizen Advisory increased its Amgen (AMGN) stake by 17% in Q4 2018, buying an estimated $52.9K and bringing the position to 1,837 shares worth $358K. The position accounts for 0.25% of the portfolio, ranked #131.

Kaizen Advisory first reported a position in AMGN in Q4 2017 and has held it in 5 quarters since. The position peaked at $1.19M in Q4 2017. 1,891 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

  • Kaizen Advisory held 1,837 shares of Amgen worth $358K as of Q4 2018.
  • Kaizen Advisory bought 271 Amgen shares in Q4 2018, an estimated $52.9K.
  • Amgen made up 0.25% of Kaizen Advisory's portfolio in Q4 2018, its #131 holding.
  • Kaizen Advisory first reported a position in Amgen in Q4 2017 and has held it in 5 quarters since.
  • Kaizen Advisory's Amgen position peaked at $1.19M in Q4 2017.
  • 1,891 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on Kaizen Advisory's 13F filing for Q4 2018, filed 15 Feb 2019.